# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018839
Filing Date
2023-05-08
Accepted
2023-05-08 16:21:14
Documents
51
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | oric-20230331.htm iXBRL | 10-Q | 2412001
2 | EX-31.1 | oric-ex31_1.htm | EX-31 | 21184
3 | EX-31.2 | oric-ex31_2.htm | EX-31 | 21170
4 | EX-32.1 | oric-ex32_1.htm | EX-32 | 11960
5 | EX-32.2 | oric-ex32_2.htm | EX-32 | 11946
| Complete submission text file | 0000950170-23-018839.txt |  | 7445007

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | oric-20230331_cal.xml | EX-101.CAL | 32243
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | oric-20230331_def.xml | EX-101.DEF | 143961
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | oric-20230331_lab.xml | EX-101.LAB | 370506
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | oric-20230331_pre.xml | EX-101.PRE | 257720
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | oric-20230331.xsd | EX-101.SCH | 37586
45 | EXTRACTED XBRL INSTANCE DOCUMENT | oric-20230331_htm.xml | XML | 1338340

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39269 | Film No.: 23898067
SIC: 2834 Pharmaceutical Preparations